discuss serena williams' glp-1 partnership Here’s the Scoop: @serena shares she is now using a #GLP1 in with Ro, a digital health care company. Find out why she’s not worried about the public’s reaction to her #weightloss journey Serena Williams Is 'Healthiest' on

Blocking GLP-1 signaling with semaglutide during this critical window could theoretically interfere with normal development, though human evidence remains limited

This trend connects to broader regimen and IP claims for combination therapies and adjuncts in obesity care [16, 17]

That you need to give people a reason that they should sustain these, because just doing it is hard, right

What target should we choose next, what modality, which indication, and crucially, how do we measure the effect on aging using reliable aging clocks

Many patients wonder whether they can discontinue GLP-1 medications like semaglutide after reaching their weight loss goals